Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDAVP population pharmacokinetics and endothelial marker study in mild hemophilia A
NL-OMON45526Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of desmopressin in hemophilia A, sponsored by Amsterdam University Medical Center. Primary endpoints: Time profile of factor VIII activity, Time profile of factor VIII antigen concentration and 1 more. Planned start Feb 2017; status: withdrawn.
02
Drugs
desmopressin
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON45526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45526.